{"id":"W4361812611","doi":"10.1158/1078-0432.c.6532298","title":"Data from A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"Merck KGaA; Pfizer","keywords":"Trabectedin; Medicine; Liposarcoma; Leiomyosarcoma; Internal medicine; Oncology; Avelumab; Urology; Sarcoma; Soft tissue sarcoma; Surgery; Cancer; Pathology; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003233405,0.001186719,0.002025491,0.0003382376,0.0004132249,0.0007226955,0.000587995,0.001045939,0.00499289],"category_scores_gemma":[0.002440017,0.0004630156,0.001437382,0.0005037524,0.0007639949,0.001207919,0.000280114,0.00214736,0.0008552696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006453472,"about_ca_system_score_gemma":0.001262406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007842567,"about_ca_topic_score_gemma":0.002144368,"domain_scores_codex":[0.9991928,0.0004923402,0.00007199743,0.00008729095,0.00008419407,0.00007141751],"domain_scores_gemma":[0.9979287,0.0008007439,0.0004214,0.0002117845,0.0001668278,0.000470525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7785004,0.01943391,0.01233544,0.002346665,0.003852794,0.0006870218,0.0002645337,0.004795762,0.0495286,0.0005094782,0.01990442,0.107841],"study_design_scores_gemma":[0.6174905,0.3151374,0.03636982,0.0001896699,0.002621752,0.001427521,0.00008736808,0.002253107,0.01065842,0.0006364343,0.01305438,0.00007356064],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9670543,0.006748918,0.002152368,0.001829234,0.0002891391,0.004789379,0.01020548,0.0001953598,0.006735769],"genre_scores_gemma":[0.9618762,0.004463288,0.003676973,0.002330958,0.0003230812,0.004840518,0.01836921,0.00007877647,0.004040909],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.00499289,"threshold_uncertainty_score":0.0171001,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.19583783990954,"score_gpt":0.410686755595673,"score_spread":0.2148489156861331,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}